Clinical trials recruiting in Cachoeiro de Itapemirim, Brazil
6
Recruiting trials
12
Conditions
Phase breakdown
Phase 3 5Not applicable 1
Conditions recruiting in Cachoeiro de Itapemirim, Brazil
Recruiting trials in Cachoeiro de Itapemirim, Brazil
- A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
- A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
- A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
- Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i.
- Neuroendocrine Carcinomas: Patient Journey And Treatment Outcomes In Latin America
- Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
Common questions
How many clinical trials are recruiting in Cachoeiro de Itapemirim, Brazil?
6 recruiting trials have at least one study site in Cachoeiro de Itapemirim, Brazil.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.